These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 7965735)
21. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze. Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124 [TBL] [Abstract][Full Text] [Related]
22. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats. Kotlinska J; Pachuta A; Bochenski M; Silberring J Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751 [TBL] [Abstract][Full Text] [Related]
23. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Decker MW; Curzon P; Brioni JD; Arnerić SP Eur J Pharmacol; 1994 Aug; 261(1-2):217-22. PubMed ID: 8001648 [TBL] [Abstract][Full Text] [Related]
24. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823 [TBL] [Abstract][Full Text] [Related]
25. Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. Levin ED; Kaplan S; Boardman A Behav Pharmacol; 1997 Jun; 8(2-3):236-42. PubMed ID: 9833018 [TBL] [Abstract][Full Text] [Related]
26. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Park JH; Cha HY; Seo JJ; Hong JT; Han K; Oh KW Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):895-900. PubMed ID: 16002200 [TBL] [Abstract][Full Text] [Related]
27. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Alcalay RN; Giladi E; Pick CG; Gozes I Neurosci Lett; 2004 May; 361(1-3):128-31. PubMed ID: 15135910 [TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist. Damaj MI; Creasy KR; Welch SP; Rosecrans JA; Aceto MD; Martin BR Psychopharmacology (Berl); 1995 Aug; 120(4):483-90. PubMed ID: 8539331 [TBL] [Abstract][Full Text] [Related]
29. Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice. O'Neill AB; Brioni JD Pharmacol Biochem Behav; 1994 Nov; 49(3):755-7. PubMed ID: 7862733 [TBL] [Abstract][Full Text] [Related]
30. Anxiolytic-like profile of propofol, a general anesthetic, in the plus-maze test in mice. Kurt M; Bilge SS; Kukula O; Celik S; Kesim Y Pol J Pharmacol; 2003; 55(6):973-7. PubMed ID: 14730091 [TBL] [Abstract][Full Text] [Related]
31. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Buccafusco JJ; Jackson WJ; Terry AV; Marsh KC; Decker MW; Arneric SP Psychopharmacology (Berl); 1995 Aug; 120(3):256-66. PubMed ID: 8524972 [TBL] [Abstract][Full Text] [Related]
32. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Decker MW; Bannon AW; Buckley MJ; Kim DJ; Holladay MW; Ryther KB; Lin NH; Wasicak JT; Williams M; Arneric SP Eur J Pharmacol; 1998 Apr; 346(1):23-33. PubMed ID: 9617748 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of anxiolytic effect and withdrawal anxiety in chronic intermittent diazepam treatment in rats. Açikmeşe B; Haznedar S; Hatipoğlu I; Enginar N Behav Pharmacol; 2012 Apr; 23(2):215-9. PubMed ID: 22327020 [TBL] [Abstract][Full Text] [Related]
34. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys. Prendergast MA; Jackson WJ; Terry AV; Decker MW; Arneric SP; Buccafusco JJ Psychopharmacology (Berl); 1998 Mar; 136(1):50-8. PubMed ID: 9537682 [TBL] [Abstract][Full Text] [Related]
35. The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines. Saitoh A; Sugiyama A; Yamada M; Inagaki M; Oka J; Nagase H; Yamada M Neuropharmacology; 2013 Apr; 67():485-93. PubMed ID: 23246531 [TBL] [Abstract][Full Text] [Related]
36. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies. Sihver W; Fasth KJ; Ogren M; Bivehed H; Bergström M; Nordberg A; Watanabe Y; Långström B J Neurochem; 1998 Oct; 71(4):1750-60. PubMed ID: 9751211 [TBL] [Abstract][Full Text] [Related]
37. Anxiolytic activity of piracetam, a nootropic agent, following subchronic administration in rodents. Bhattacharya SK; Sen AP; Upadhyay SN; Jaiswal AK Indian J Exp Biol; 1993 Nov; 31(11):902-7. PubMed ID: 7906672 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine. Badio B; Garraffo HM; Plummer CV; Padgett WL; Daly JW Eur J Pharmacol; 1997 Feb; 321(2):189-94. PubMed ID: 9063687 [TBL] [Abstract][Full Text] [Related]
39. Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Turchi J; Holley LA; Sarter M Psychopharmacology (Berl); 1995 Mar; 118(2):195-205. PubMed ID: 7617808 [TBL] [Abstract][Full Text] [Related]
40. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Wright IK; Heaton M; Upton N; Marsden CA Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]